June 11, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
ACG: New blood-based CRC test guidance asks ‘too much’ of patients navigating screening
ACG has issued a statement urging clinicians to interpret American Cancer Society’s revised colorectal cancer screening guidance with caution.In the statement, ACG expressed concern that the recommendation of blood-based tests for some patients risks undermining adherence to higher-sensitivity screening options.
TL;DRAI
American Cancer Society endorses blood-based CRC screening (Shield); ACG cautions it misses 1 in 3 early cases versus colonoscopy's 95%+ accuracy. Healthcare IT vendors face rising demand for patient education platforms clarifying screening guidelines to improve compliance.
1,094 words~5 min read
